EXTENDED REPORT

¹ Division of Rheumatology, University of Geneva, Switzerland
² SCQM Foundation, Institute of Social and Preventive Medicine, University of Zurich, Switzerland
³ Division of Rheumatology, Allergy and Immunology, Brigham and Women’s Hospital, Boston, United States

Correspondence to:
Dr A Finckh
Division of Rheumatology, Department of Internal Medicine, University Hospital of Geneva, 26 Av. Beau-Sejour, 1211 Geneva 14, Switzerland; axel.finckh{at}hcuge.ch

Background: Smoking is a well-established environmental risk factor for the development of rheumatoid arthritis (RA). However, it remains unclear whether smoking influences RA disease progression and whether smokers have more radiographic damage progression than non-smokers over time.

Objective: To compare the rates of radiographic damage progression in current smokers and non-smokers in a large prospective RA cohort.

Methods: The SCQM-RA is a population-based registry monitoring disease activity, radiographic damage and symptoms at regular intervals. All patients in the SCQM-RA database with sequential plain radiographs were included. Joint erosions were assessed in 38 hand and foot joints with a validated scoring method. The rate of erosion progression was analysed using multivariate longitudinal regression models and adjusted for potential confounders.

Results: 2004 RA patients with a mean of 3.6 sequential radiographs and 3.1 years of follow-up were included. The 545 (27%) current smokers smoked on average 16 cigarettes per day and had a mean past smoking exposure of 20.6 pack-years. Radiographic joint damage progressed at a similar rate in current smokers and non-smokers (p = 0.26). However, smoking intensity was associated with a significant inverse dose–response; heavy smokers (>1 pack-day) progressed significantly less than non-smokers or moderate smokers (p<0.001).

Conclusion: Radiographic joint damage progressed at an equivalent rate in smokers and non-smokers. Furthermore, a significant trend was observed for reduced radiographic progression and generally more favourable functional scores among heavy smokers, suggesting that cigarette smoke does not accelerate RA disease progression.

Abbreviations: rheumatoid arthritis; joint damage; environmental exposures; smoking; HAQ, Health Assessment Questionnaire; ICC, intraclass correlation coefficient; RA, rheumatoid arthritis; RF, rheumatoid factor; SCQM-RA, Swiss Clinical Quality Management programme for RA

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• MATTEY, D. L., BROWNFIELD, A., DAWES, P. T. (2009). Relationship Between Pack-year History of Smoking and Response to Tumor Necrosis Factor Antagonists in Patients with Rheumatoid Arthritis. The Journal of Rheumatology 36: 1180-1187 [Abstract] [Full Text]  
• Hetland, M L, Ejbjerg, B, Horslev-Petersen, K, Jacobsen, S, Vestergaard, A, Jurik, A G, Stengaard-Pedersen, K, Junker, P, Lottenburger, T, Hansen, I, Andersen, L S, Tarp, U, Skjodt, H, Pedersen, J K, Majgaard, O, Svendsen, A J, Ellingsen, T, Lindegaard, H, Christensen, A F, Vallo, J, Torfing, T, Narvestad, E, Thomsen, H S, Ostergaard, M, and the CIMESTRA study group, (2009). MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 68: 384-390 [Abstract] [Full Text]  
• Kobayashi, S., Okamoto, H., Iwamoto, T., Toyama, Y., Tomatsu, T., Yamanaka, H., Momohara, S. (2008). A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 47: 1317-1322 [Abstract] [Full Text]  
• Westhoff, G., Rau, R., Zink, A. (2008). Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 47: 849-854 [Abstract] [Full Text]